What to do for a persistent cough after using albuterol (salbutamol), Tessalon Perles (benzocaine), and QVAR (beclomethasone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Persistent Cough After Albuterol, Tessalon Perles, and QVAR

For persistent cough despite albuterol, Tessalon Perles, and QVAR (beclomethasone), add inhaled ipratropium bromide as the next step, followed by a short course of oral prednisone (30-40 mg daily) if ipratropium fails and other common causes have been excluded. 1

Immediate Next Steps

First-Line Addition: Inhaled Ipratropium

  • Ipratropium bromide is the only inhaled anticholinergic specifically recommended for cough suppression in postinfectious or persistent cough. 1
  • This medication may attenuate the cough through its anticholinergic effects on airway secretions and bronchial smooth muscle. 1
  • Ipratropium has fair evidence (Grade B recommendation) for reducing cough frequency in patients with persistent cough not responding to initial bronchodilator and inhaled corticosteroid therapy. 1

Second-Line: Oral Corticosteroids

  • If ipratropium fails and the cough adversely affects quality of life, prescribe prednisone 30-40 mg daily for a short, finite period (typically 5-7 days). 1
  • This approach is specifically recommended for severe paroxysms of postinfectious cough when other common causes (upper airway cough syndrome, asthma, gastroesophageal reflux) have been ruled out. 1
  • The evidence level is low but the net benefit is intermediate (Grade C recommendation). 1

Important Diagnostic Considerations

Rule Out ACE Inhibitor-Induced Cough

  • If the patient is taking any ACE inhibitor (captopril, enalapril, lisinopril, ramipril, perindopril, etc.), this must be stopped immediately as it is the most common medication-related cause of persistent dry cough. 1, 2, 3
  • ACE inhibitor cough occurs in 5-50% of patients (higher in Chinese populations), is characteristically non-productive with a persistent tickle in the throat, and typically resolves within 1-2 weeks of discontinuation. 1, 2
  • Switch to an angiotensin receptor blocker (ARB) such as losartan 25-50 mg daily or candesartan 4-8 mg daily if the ACE inhibitor was being used for hypertension or heart failure. 2, 3

Consider Pertussis

  • If cough has lasted ≥2 weeks with paroxysms, post-tussive vomiting, or inspiratory whooping sound, obtain nasopharyngeal culture or swab for Bordetella pertussis (Grade B recommendation). 1
  • If pertussis is confirmed or highly suspected, treat with a macrolide antibiotic (azithromycin or clarithromycin) and isolate for 5 days. 1

Assess for Non-Eosinophilic Bronchitis or Asthma

  • The patient has already tried QVAR (beclomethasone), but if this was only used briefly or at low doses, consider increasing the dose or extending the duration before abandoning inhaled corticosteroids. 1, 4
  • Extra-fine beclomethasone 400 mcg twice daily for 7 days followed by 200 mcg twice daily for 4 days has shown efficacy in reducing postinfectious persistent cough (p<0.05). 4

Third-Line Options If Above Measures Fail

Central Antitussives

  • Codeine (30 mg three times daily) or dextromethorphan (30 mg as needed) should be considered when other measures fail. 1
  • These have fair evidence (Grade B for codeine) for chronic bronchitis but limited efficacy for upper respiratory infection-related cough. 1
  • Codeine reduces cough frequency by 40-60% in chronic bronchitis patients but has side effects including drowsiness, constipation, and potential dependence. 1, 5

Peripheral Cough Suppressants

  • Levodropropizine or moguisteine are recommended for short-term symptomatic relief in chronic or acute bronchitis (Grade A recommendation), though these may not be readily available in all countries. 1

What NOT to Do

Ineffective Interventions

  • Albuterol alone is not recommended for cough not due to asthma (Grade D recommendation). 1
  • Over-the-counter combination cold medications (except older antihistamine-decongestant combinations) are not recommended until proven effective in trials. 1
  • Zinc preparations are not recommended for acute cough due to common cold (Grade D). 1
  • Mucolytic agents have no role in cough suppression for chronic bronchitis (Grade D). 1

Common Pitfall: QVAR-Induced Cough

  • Paradoxically, beclomethasone (QVAR) itself can cause cough and wheezing in 20% of asthmatic patients. 6
  • If the cough worsened after starting QVAR, consider that the inhaled corticosteroid may be the culprit rather than the solution. 6
  • Pretreatment with albuterol before QVAR inhalation can attenuate this side effect in some patients. 6

Algorithm Summary

  1. Stop any ACE inhibitor immediately if present 1, 2, 3
  2. Add ipratropium bromide (first-line addition) 1
  3. If no improvement in 1-2 weeks, add prednisone 30-40 mg daily for 5-7 days 1
  4. If still persistent, add codeine 30 mg three times daily or dextromethorphan 1
  5. Consider pertussis testing if paroxysmal features present 1
  6. Evaluate whether QVAR itself is causing cough - if so, pretreat with albuterol or discontinue 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Switching from Perindopril to ARB for ACE Inhibitor-Induced Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of ACE Inhibitor-Induced Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical efficacy of short-term treatment with extra-fine HFA beclomethasone dipropionate in patients with post-infectious persistent cough.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2007

Research

Drugs to suppress cough.

Expert opinion on investigational drugs, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.